Host defenses: development and maternal contributions.

A. S. Goldman, A. J. Ham Pong, R. M. Goldblum

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

During the intrauterine period, the human immunologic system develops through a complex but orderly series of events. The functional capacity of the system remains incomplete, not only during prenatal life but also through much of infancy. Many of the factors not produced by the fetus or infant are provided by the mother. Systemic immunity is augmented by specific IgG antibodies from the placenta and mucosal immunity by a wide array of defense agents from human milk including sIgA antibodies, lactoferrin, lysozyme, other soluble factors with antimicrobial properties, and specifically adapted leukocytes. It appears that the defense of the infant and the maternal contribution to that defense are geared to protect principally by noninflammatory mechanisms. Although much has been discovered about the ontogeny of the human immunologic system and the maternal contributions to this immunity, much remains to be learned about the molecular controls of the system, the fate of the transported maternal factors, feedback mechanisms between the immunologic systems of the mother and infant and the precise effects of maternal factors upon the infant. Answers to these questions may lead to the development of immunizing agents which are better suited to the infant, mucosal immunogens fashioned to stimulate the production of protective SIgA antibodies in human milk, the provision of defense factors for serious infections in young infants, and ways to enhance the maturation of the immunologic system of the infant when that is desirable.

Original languageEnglish (US)
Pages (from-to)71-100
Number of pages30
JournalAdvances in Pediatrics
Volume32
StatePublished - 1985
Externally publishedYes

Fingerprint

Mothers
Human Milk
Antibodies
Immunity
Secretory Immunoglobulin A
Mucosal Immunity
Lactoferrin
Muramidase
Placenta
Fetus
Leukocytes
Immunoglobulin G
Infection

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Goldman, A. S., Ham Pong, A. J., & Goldblum, R. M. (1985). Host defenses: development and maternal contributions. Advances in Pediatrics, 32, 71-100.

Host defenses : development and maternal contributions. / Goldman, A. S.; Ham Pong, A. J.; Goldblum, R. M.

In: Advances in Pediatrics, Vol. 32, 1985, p. 71-100.

Research output: Contribution to journalArticle

Goldman, AS, Ham Pong, AJ & Goldblum, RM 1985, 'Host defenses: development and maternal contributions.', Advances in Pediatrics, vol. 32, pp. 71-100.
Goldman AS, Ham Pong AJ, Goldblum RM. Host defenses: development and maternal contributions. Advances in Pediatrics. 1985;32:71-100.
Goldman, A. S. ; Ham Pong, A. J. ; Goldblum, R. M. / Host defenses : development and maternal contributions. In: Advances in Pediatrics. 1985 ; Vol. 32. pp. 71-100.
@article{d02543e8019c40bea66d07c60803aea4,
title = "Host defenses: development and maternal contributions.",
abstract = "During the intrauterine period, the human immunologic system develops through a complex but orderly series of events. The functional capacity of the system remains incomplete, not only during prenatal life but also through much of infancy. Many of the factors not produced by the fetus or infant are provided by the mother. Systemic immunity is augmented by specific IgG antibodies from the placenta and mucosal immunity by a wide array of defense agents from human milk including sIgA antibodies, lactoferrin, lysozyme, other soluble factors with antimicrobial properties, and specifically adapted leukocytes. It appears that the defense of the infant and the maternal contribution to that defense are geared to protect principally by noninflammatory mechanisms. Although much has been discovered about the ontogeny of the human immunologic system and the maternal contributions to this immunity, much remains to be learned about the molecular controls of the system, the fate of the transported maternal factors, feedback mechanisms between the immunologic systems of the mother and infant and the precise effects of maternal factors upon the infant. Answers to these questions may lead to the development of immunizing agents which are better suited to the infant, mucosal immunogens fashioned to stimulate the production of protective SIgA antibodies in human milk, the provision of defense factors for serious infections in young infants, and ways to enhance the maturation of the immunologic system of the infant when that is desirable.",
author = "Goldman, {A. S.} and {Ham Pong}, {A. J.} and Goldblum, {R. M.}",
year = "1985",
language = "English (US)",
volume = "32",
pages = "71--100",
journal = "Advances in Pediatrics",
issn = "0065-3101",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Host defenses

T2 - development and maternal contributions.

AU - Goldman, A. S.

AU - Ham Pong, A. J.

AU - Goldblum, R. M.

PY - 1985

Y1 - 1985

N2 - During the intrauterine period, the human immunologic system develops through a complex but orderly series of events. The functional capacity of the system remains incomplete, not only during prenatal life but also through much of infancy. Many of the factors not produced by the fetus or infant are provided by the mother. Systemic immunity is augmented by specific IgG antibodies from the placenta and mucosal immunity by a wide array of defense agents from human milk including sIgA antibodies, lactoferrin, lysozyme, other soluble factors with antimicrobial properties, and specifically adapted leukocytes. It appears that the defense of the infant and the maternal contribution to that defense are geared to protect principally by noninflammatory mechanisms. Although much has been discovered about the ontogeny of the human immunologic system and the maternal contributions to this immunity, much remains to be learned about the molecular controls of the system, the fate of the transported maternal factors, feedback mechanisms between the immunologic systems of the mother and infant and the precise effects of maternal factors upon the infant. Answers to these questions may lead to the development of immunizing agents which are better suited to the infant, mucosal immunogens fashioned to stimulate the production of protective SIgA antibodies in human milk, the provision of defense factors for serious infections in young infants, and ways to enhance the maturation of the immunologic system of the infant when that is desirable.

AB - During the intrauterine period, the human immunologic system develops through a complex but orderly series of events. The functional capacity of the system remains incomplete, not only during prenatal life but also through much of infancy. Many of the factors not produced by the fetus or infant are provided by the mother. Systemic immunity is augmented by specific IgG antibodies from the placenta and mucosal immunity by a wide array of defense agents from human milk including sIgA antibodies, lactoferrin, lysozyme, other soluble factors with antimicrobial properties, and specifically adapted leukocytes. It appears that the defense of the infant and the maternal contribution to that defense are geared to protect principally by noninflammatory mechanisms. Although much has been discovered about the ontogeny of the human immunologic system and the maternal contributions to this immunity, much remains to be learned about the molecular controls of the system, the fate of the transported maternal factors, feedback mechanisms between the immunologic systems of the mother and infant and the precise effects of maternal factors upon the infant. Answers to these questions may lead to the development of immunizing agents which are better suited to the infant, mucosal immunogens fashioned to stimulate the production of protective SIgA antibodies in human milk, the provision of defense factors for serious infections in young infants, and ways to enhance the maturation of the immunologic system of the infant when that is desirable.

UR - http://www.scopus.com/inward/record.url?scp=0022293138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022293138&partnerID=8YFLogxK

M3 - Article

C2 - 3909786

AN - SCOPUS:0022293138

VL - 32

SP - 71

EP - 100

JO - Advances in Pediatrics

JF - Advances in Pediatrics

SN - 0065-3101

ER -